Nigel J Dimmock

Author PubWeight™ 13.49^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function.	Virology	2005	1.05
2	Characterization of a human immunodeficiency virus type 1 pre-integration complex in which the majority of the cDNA is resistant to DNase I digestion.	J Gen Virol	2002	1.03
3	A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.	Vaccine	2011	1.01
4	A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.	J Gen Virol	2003	0.99
5	Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.	Vaccine	2004	0.95
6	Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus.	J Gen Virol	2011	0.91
7	Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance.	Bioorg Med Chem	2004	0.86
8	Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.	Vaccine	2011	0.86
9	The receptor preference of influenza viruses.	Influenza Other Respir Viruses	2010	0.85
10	A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progeny.	Virology	2003	0.84
11	Valency of antibody binding to enveloped virus particles as determined by surface plasmon resonance.	J Virol	2003	0.84
12	Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion.	J Gen Virol	2005	0.84
13	Analysis of a 17-amino acid residue, virus-neutralizing microantibody.	J Gen Virol	2005	0.84
14	Defective interfering virus protects elderly mice from influenza.	Virol J	2011	0.83
15	An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion.	J Gen Virol	2005	0.81